| ZA991578B (en) | | Compounds for the treatment of ischemia. |
| HUP0100765A3 (en) | | Composition for the treatment of halitosis |
| IL148222A0 (en) | | Compounds for the treatment of ischemia |
| GB9804734D0 (en) | | Compounds |
| GB9804175D0 (en) | | Compounds |
| GB9812038D0 (en) | | Therapeutic compound |
| IL129906A0 (en) | | Process for the preparation of beta-isophorone |
| GB9926537D0 (en) | | Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds |
| GB0226147D0 (en) | | Treatment for multiple sclerosis |
| AU3187595A (en) | | Compounds for the treatment of restenosis |
| HUP0101947A3 (en) | | Combination for the treatment of tumors |
| IL133760A0 (en) | | Composition for the treatment of dandruff |
| GB9824897D0 (en) | | Therapeutic compounds |
| AU1940800A (en) | | Combination therapy for the treatment of sepsis |
| GB9801712D0 (en) | | Compounds |
| HUP9902745A3 (en) | | Process for the preparation of benzylcarbazate |
| GB9817095D0 (en) | | Compounds for the treatment of multiple sclerosis |
| GB9808667D0 (en) | | Therapeutic compounds |
| IL127227A0 (en) | | A pharmaceutical composition for the treatment of multiple sclerosis |
| SI1068199T1 (en) | | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
| GB9810855D0 (en) | | Use of compounds |
| IL124878A0 (en) | | Composition for the treatment of seborrhea |
| IL114089A0 (en) | | Methods for the preparation of alpha-chloroacetoacetanilide compounds |
| GB9821690D0 (en) | | Therapeutic compounds |
| GB9821541D0 (en) | | Therapeutic compounds |